KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer

BACKGROUND: In spite of great progress in the surgical and clinical management, until now no significant improvement in overall survival of High-Grade Serous Ovarian Cancer (HGSOC) patients has been achieved. Important aspects for disease control remain unresolved, including unclear pathogenesis, hi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Clin Cancer Res
Autors principals: De Donato, Marta, Babini, Gabriele, Mozzetti, Simona, Buttarelli, Marianna, Ciucci, Alessandra, Arduini, Gloria, De Rosa, Maria Cristina, Scambia, Giovanni, Gallo, Daniela
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7702713/
https://ncbi.nlm.nih.gov/pubmed/33250051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01775-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars